Description
A Nrf2 activator that interacts directly with the domain containing the Nrf2-binding site of Keap1; downregulates the expression of fibrogenic genes, producing antifibrotic effects in a rat model of non-alcoholic steatohepatitis
Formal name: N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-N’-(2-pyridinylmethyl)-urea
Synonyms:
Molecular weight: 285.3
CAS: 1414963-82-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Activators|Transcription Factors & Coactivators||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity
